Comments
Loading...

ARS Pharmaceuticals

SPRYNASDAQ
Logo brought to you by Benzinga Data
$14.71
0.634.47%
Pre-Market: 7:38 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
The most recent conference call was at 8:00 AM, 1 day ago Click to view past webcast

ARS Pharmaceuticals (NASDAQ:SPRY) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for ARS Pharmaceuticals (SPRY)?

A

There have been no specific sales or earnings guidance reported for ARS Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch